Business

Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously

- COVID-19 vaccine candidate efficacy in those 18

articleNovavax, Inc.June 14, 20213/company/novavax-inc/news/novavax-announces-positive-results-from-first-study-of-influenza-vaccine-and-covid-19-vaccine-candidate-administered-simultaneously
Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously

About this update from Novavax, Inc.

[{"type":"text","content":"- COVID-19 vaccine candidate efficacy in those 18 to","length":56,"tagName":"div"}]

More updates from Novavax, Inc.